Results 131 to 140 of about 37,394 (238)

High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.

Biology of Blood and Marrow Transplantation, 2018
The kidney is the most common organ affected by immunoglobulin light-chain (AL) amyloidosis and monoclonal immunoglobulin deposition disease (MIDD), often leading to end-stage renal disease (ESRD).
F. Batalini, L. Econimo, K. Quillen, J. M. Sloan, S. Sarosiek, D. Brauneis, A. Havasi, L. Stern, L. Dember, V. Sanchorawala   +9 more
semanticscholar   +1 more source

The pathological diagnosis of nerve biopsies: a practical approach [PDF]

, 2016
The approach to the neuropathological assessment of nerve biopsies is the main focus of this review. Nerve biopsies are invasive diagnostic procedures resulting in a permanent neurological deficit, and are therefore carried out only following an in-depth
Brandner, S
core   +1 more source

Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis [PDF]

, 2013
Background: We compared a novel assay for free light chain (FLC) quantitation based on monoclonal antibodies (N-Latex, Siemens, Germany) to the established polyclonal antibody-based assay (Freelite (TM), The Binding Site, UK) in AL ...
Campbell, Campbell, Comenzo, Comenzo, Davern, Davern, Dispenzieri, Dispenzieri, Katzmann, Katzmann, Kumar, Kumar, Kumar, Kumar, Lachmann, Lachmann, Mollee, Mollee, Morris, Morris, Palladini, Palladini, Palladini, Palladini, Palladini, Palladini, Pretorius, Pretorius, Tate, Tate, Tate, Tate, Velthuis, Velthuis   +33 more
core   +1 more source

Daratumumab for Immunoglobulin Light Chain Amyloidosis [PDF]

Oncology & Haematology, 2021
Theodorakakou, Foteini, Dimopoulos, Meletios A., Kastritis, Efstathios   +2 more
openaire   +2 more sources

Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. [PDF]

, 2014
To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.In 728 Swedish cases of monoclonal gammopathy of undetermined significance (MGUS), followed up to 30 years (median, 10 years), we estimated ...
Drayson, Mark T., Goldin, Lynn R., Kovalchik, Stephanie A., Kristinsson, Sigurdur Y., Landgren, Carl, Landgren, Ola, Pfeiffer, Ruth M., Turesson, Ingemar   +7 more
core   +1 more source

A risk stratification for systemic immunoglobulin light‐chain amyloidosis with renal involvement

British Journal of Haematology, 2019
Renal involvement is found in about 70% of patients with systemic immunoglobulin light‐chain (AL) amyloidosis. However, there is no risk stratification system specialized for renal AL concerning patients’ survival. Galectin‐3 (Gal‐3) has been reported to
Ting Li, Xianghua Huang, Qingwen Wang, Liang Zhao, G. Ren, Wencui Chen, C. Zheng, Minlin Zhou, Qi Jiang, Ru Yin, Zhihong Liu   +10 more
semanticscholar   +1 more source

Amiloidose renal: classificação de 102 casos consecutivos [PDF]

, 2014
Amyloidoses are a group of heterogeneous diseases classified according to the nature of their causative amyloid proteins. Commonly, paraffin-embedded tissue is used for the typing of amyloid by immunohistochemistry.
Lobato, L., Moreira, L., Oliveira, J., Pereira, P., Pinho-Costa, P., Sampaio, S., Tavares, I., Vaz, R., Vizcaíno, J.   +8 more
core  

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis [PDF]

, 2017
Aims: Congo red staining of an endomyocardial biopsy is the diagnostic gold-standard in suspected cardiac amyloidosis (CA), but the procedure is associated with the risk, albeit small, of serious complications, and delay in diagnosis due to the ...
Botcher, N, Fontana, M, Gilbertson, JA, Gillmore, JD, Gonzalez-Lopez, E, Hawkins, PN, Lachmann, HJ, Mahmood, S, Petrie, A, Quarta, CC, Rezk, T, Rowczenio, D, Sachchithanantham, S, Wechalekar, AD, Whelan, CJ, Youngstein, T   +15 more
core   +1 more source

Multiple Myeloma and AL Amyloidosis [PDF]

, 2016
O mieloma múltiplo e a amiloidose de cadeias leves (AL) de imunoglobulina são doenças proliferativas plasmocitárias incuráveis que raramente coexistem. Cerca de 10 a 15% dos doentes com mieloma múltiplo desenvolvem amiloidose AL clinicamente sintomática,
Alcatrão, M, Bravo, A, Estrada, H, Gaspar, A, Margarido, E, Neves, C   +5 more
core  

A patient with AL amyloidosis presenting with refractory tuberculosis, chest tightness and hypotension: case report

BMC Pulmonary Medicine
Introduction Immunoglobulin light chain (AL) amyloidosis presents a clinical spectrum characterized by diverse manifestations and involvement of multiple organs, posing a significant diagnostic challenge for physicians.
Jun Yang, Mohamed Fahim Fathima Farhath, Huohuan Tian, Linhui Yang, Dan Liu   +4 more
doaj   +1 more source